Suppr超能文献

使用粪便细菌疗法治疗溃疡性结肠炎。

Treatment of ulcerative colitis using fecal bacteriotherapy.

作者信息

Borody Thomas J, Warren Eloise F, Leis Sharyn, Surace Rosa, Ashman Ori

机构信息

Centre for Digestive Diseases, 144 Great North Rd, Five Dock NSW 2046, Australia.

出版信息

J Clin Gastroenterol. 2003 Jul;37(1):42-7. doi: 10.1097/00004836-200307000-00012.

Abstract

BACKGROUND

Although the etiology of idiopathic ulcerative colitis (UC) remains poorly understood, the intestinal flora is suspected to play an important role. Specific, consistent abnormalities in flora composition peculiar to UC have not yet been described, however Clostridium difficile colitis has been cured by the infusion of human fecal flora into the colon. This approach may also be applicable to the treatment of UC on the basis of restoration of flora imbalances.

GOAL

To observe the clinical, colonoscopic and histologic effects of human probiotic infusions (HPI) in 6 selected patients with UC.

CASE REPORTS

Six patients (3 men and 3 women aged 25-53 years) with UC for less than 5 years were treated with HPI. All patients had suffered severe, recurrent symptoms and UC had been confirmed on colonoscopy and histology. Fecal flora donors were healthy adults who were extensively screened for parasites and bacterial pathogens. Patients were prepared with antibiotics and oral polyethylene glycol lavage. Fecal suspensions were administered as retention enemas within 10 minutes of preparation and the process repeated daily for 5 days. By 1 week post-HPI some symptoms of UC had improved. Complete reversal of symptoms was achieved in all patients by 4 months post-HPI, by which time all other UC medications had been ceased. At 1 to 13 years post-HPI and without any UC medication, there was no clinical, colonoscopic, or histologic evidence of UC in any patient.

CONCLUSIONS

Colonic infusion of donor human intestinal flora can reverse UC in selected patients. These anecdotal results support the concept of abnormal bowel flora or even a specific, albeit unidentified, bacterial pathogen causing UC.

摘要

背景

尽管特发性溃疡性结肠炎(UC)的病因仍未完全明确,但肠道菌群被怀疑发挥着重要作用。然而,尚未发现UC特有的菌群组成存在特定、一致的异常情况,不过艰难梭菌性结肠炎已通过向结肠输注人粪便菌群得以治愈。基于恢复菌群失衡,这种方法可能也适用于UC的治疗。

目的

观察6例选定的UC患者接受人益生菌输注(HPI)后的临床、结肠镜及组织学效果。

病例报告

6例UC病程小于5年的患者(3男3女,年龄25 - 53岁)接受了HPI治疗。所有患者均有严重的复发症状,且结肠镜检查和组织学检查确诊为UC。粪便菌群供体为经过寄生虫和细菌病原体广泛筛查的健康成年人。患者先使用抗生素并口服聚乙二醇进行肠道准备。粪便悬液在制备后10分钟内作为保留灌肠剂给药,每天重复此过程,持续5天。HPI后1周,一些UC症状有所改善。HPI后4个月,所有患者症状完全缓解,此时所有其他UC药物均已停用。HPI后1至13年,且未使用任何UC药物,所有患者均无UC的临床、结肠镜或组织学证据。

结论

向结肠输注供体人肠道菌群可使选定患者的UC病情逆转。这些个案结果支持肠道菌群异常甚至存在一种特定的(尽管尚未明确)细菌病原体导致UC的观点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验